Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312117003> ?p ?o ?g. }
- W4312117003 endingPage "65" @default.
- W4312117003 startingPage "65" @default.
- W4312117003 abstract "Chemotherapy has been the predominant treatment modality for cancer patients, but its overall performance is still modest. Difficulty in penetration of tumor tissues, a toxic profile in high doses, multidrug resistance in an array of tumor types, and the differential architecture of tumor cells as they grow are some of the bottlenecks associated with the clinical usage of chemotherapeutics. Recent advances in tumor biology understanding and the emergence of novel targeted drug delivery tools leveraging various nanosystems offer hope for developing effective cancer treatments. Topotecan is a topoisomerase I inhibitor that stabilizes the transient TOPO I-DNA cleavable complex, leading to single-stranded breaks in DNA. Due to its novel mechanism of action, TOPO is reported to be active against various carcinomas, namely small cell lung cancer, cervical cancer, breast cancer, and ovarian cancer. Issues of cross-resistance with numerous drugs, rapid conversion to its inactive form in biological systems, appended adverse effects, and higher water solubility limit its therapeutic efficacy in clinical settings. Topotecan nanoformulations offer several benefits for enhancing the therapeutic action of this significant class of chemotherapeutics. The likelihood that the target cancer cells will be exposed to the chemotherapeutic drug while in the drug-sensitive s-phase is increased due to the slow and sustained release of the chemotherapeutic, which could provide for a sustained duration of exposure of the target cancer cells to the bioavailable drug and result in the desired therapeutic outcome. This article explores nanoenabled active and passive targeting strategies and combinatorial therapy employing topotecan to ameliorate various cancers, along with a glimpse of the clinical studies utilizing the said molecule." @default.
- W4312117003 created "2023-01-04" @default.
- W4312117003 creator A5005355709 @default.
- W4312117003 creator A5010853448 @default.
- W4312117003 creator A5012660773 @default.
- W4312117003 creator A5023869025 @default.
- W4312117003 creator A5041159277 @default.
- W4312117003 creator A5041421375 @default.
- W4312117003 creator A5041987514 @default.
- W4312117003 creator A5064201124 @default.
- W4312117003 creator A5072043849 @default.
- W4312117003 creator A5080330840 @default.
- W4312117003 creator A5080368161 @default.
- W4312117003 creator A5086120964 @default.
- W4312117003 creator A5089627009 @default.
- W4312117003 creator A5090747664 @default.
- W4312117003 date "2022-12-22" @default.
- W4312117003 modified "2023-10-10" @default.
- W4312117003 title "Nanoplatform for the Delivery of Topotecan in the Cancer Milieu: An Appraisal of its Therapeutic Efficacy" @default.
- W4312117003 cites W1573363574 @default.
- W4312117003 cites W159145295 @default.
- W4312117003 cites W1707033507 @default.
- W4312117003 cites W1871475547 @default.
- W4312117003 cites W1975574746 @default.
- W4312117003 cites W1986536800 @default.
- W4312117003 cites W1996463727 @default.
- W4312117003 cites W2026146066 @default.
- W4312117003 cites W2026567177 @default.
- W4312117003 cites W2033656497 @default.
- W4312117003 cites W2044358936 @default.
- W4312117003 cites W2050981032 @default.
- W4312117003 cites W2059699128 @default.
- W4312117003 cites W2061318159 @default.
- W4312117003 cites W2068577449 @default.
- W4312117003 cites W2070171305 @default.
- W4312117003 cites W2081595330 @default.
- W4312117003 cites W2082046119 @default.
- W4312117003 cites W2083803551 @default.
- W4312117003 cites W2096559247 @default.
- W4312117003 cites W2101928585 @default.
- W4312117003 cites W2132521183 @default.
- W4312117003 cites W2137797191 @default.
- W4312117003 cites W2142197209 @default.
- W4312117003 cites W2155610829 @default.
- W4312117003 cites W2171665032 @default.
- W4312117003 cites W2300491666 @default.
- W4312117003 cites W2316842585 @default.
- W4312117003 cites W2399911666 @default.
- W4312117003 cites W2410631057 @default.
- W4312117003 cites W2415847618 @default.
- W4312117003 cites W2600452401 @default.
- W4312117003 cites W2731620928 @default.
- W4312117003 cites W2735677605 @default.
- W4312117003 cites W2770767649 @default.
- W4312117003 cites W2802392271 @default.
- W4312117003 cites W2883751717 @default.
- W4312117003 cites W2957984348 @default.
- W4312117003 cites W2986260879 @default.
- W4312117003 cites W3004971621 @default.
- W4312117003 cites W3022660887 @default.
- W4312117003 cites W3034111719 @default.
- W4312117003 cites W3035320234 @default.
- W4312117003 cites W3080201597 @default.
- W4312117003 cites W3085093963 @default.
- W4312117003 cites W3105774807 @default.
- W4312117003 cites W3124272572 @default.
- W4312117003 cites W3131796252 @default.
- W4312117003 cites W3134576072 @default.
- W4312117003 cites W3161875879 @default.
- W4312117003 cites W3175179318 @default.
- W4312117003 cites W3179910630 @default.
- W4312117003 cites W3188207528 @default.
- W4312117003 cites W3209473231 @default.
- W4312117003 cites W3209705836 @default.
- W4312117003 cites W4234855942 @default.
- W4312117003 cites W4239535775 @default.
- W4312117003 cites W4243481281 @default.
- W4312117003 doi "https://doi.org/10.3390/cancers15010065" @default.
- W4312117003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36612067" @default.
- W4312117003 hasPublicationYear "2022" @default.
- W4312117003 type Work @default.
- W4312117003 citedByCount "1" @default.
- W4312117003 crossrefType "journal-article" @default.
- W4312117003 hasAuthorship W4312117003A5005355709 @default.
- W4312117003 hasAuthorship W4312117003A5010853448 @default.
- W4312117003 hasAuthorship W4312117003A5012660773 @default.
- W4312117003 hasAuthorship W4312117003A5023869025 @default.
- W4312117003 hasAuthorship W4312117003A5041159277 @default.
- W4312117003 hasAuthorship W4312117003A5041421375 @default.
- W4312117003 hasAuthorship W4312117003A5041987514 @default.
- W4312117003 hasAuthorship W4312117003A5064201124 @default.
- W4312117003 hasAuthorship W4312117003A5072043849 @default.
- W4312117003 hasAuthorship W4312117003A5080330840 @default.
- W4312117003 hasAuthorship W4312117003A5080368161 @default.
- W4312117003 hasAuthorship W4312117003A5086120964 @default.
- W4312117003 hasAuthorship W4312117003A5089627009 @default.
- W4312117003 hasAuthorship W4312117003A5090747664 @default.
- W4312117003 hasBestOaLocation W43121170031 @default.